SCHEMBL801164

SCHEMBL801164

CC(C)(C)c1ccc(-n2c3ccc(P(=O)(c4ccccc4)c4ccccc4)cc3c3cc(P(=O)(c4ccccc4)c4ccccc4)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 8/20 0.41
▸ NR1H4 Q96RI1 3/20 0.39
▸ PPARA Q07869 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.38
▸ MDM2 Q00987 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PTGES O14684 1/20 0.36
▸ PMM2 O15305 1/20 0.36
▸ MPI P34949 1/20 0.36
▸ PHOSPHO1 Q8TCT1 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ PGR P06401 1/20 0.35
▸ RORA P35398 1/20 0.35
▸ RORC P51449 1/20 0.35
▸ RORB Q92753 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL801335 0.97 PPARG (0.39) PPARGNR1H4PPARANPSR1MDM2
SCHEMBL801604 0.97 PPARG (0.38) PPARGNR1H4PPARANPSR1MDM2
SCHEMBL801600 0.96 PPARG (0.39) PPARGNR1H4PPARANPSR1MDM2
SCHEMBL801721 0.94 PPARG (0.42) PPARGNR1H4PPARANPSR1MDM2
SCHEMBL801194 0.93 PPARG (0.37) PPARGNR1H4PPARANPSR1MDM2
SCHEMBL801165 0.91 PPARG (0.38) PPARGNR1H4PPARANPSR1MDM2
SCHEMBL801597 0.91 PPARG (0.36) PPARGNR1H4PPARANPSR1MDM2
SCHEMBL801103 0.90 KDM4E (0.42) NPSR1KDM4EMEN1MAPTRAB9A
SCHEMBL801196 0.90 NPSR1 (0.38) PPARGNR1H4PPARANPSR1KDM4E
SCHEMBL801193 0.89 NPSR1 (0.37) PPARGNR1H4PPARANPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 PPARG 1500/4885NR1H4 4304/4885PPARA 1218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback